Event-Driven Stocks

AQUABOUNTY TECHNOLOGIES INC

AQBNasdaqCompleted

Formerly AquaBounty Technologies, Inc.

Spin-offSpun off from IntrexonPGENNasdaq

The two companies

Parent
IntrexonPGENNasdaq
Pharmaceutical Preparations
↓ spun off ↓

Open either company's hub for its full SEC financials, ratios, ownership, filings, and every other event it's been part of.

Sector
Materials
Industry
Fishing, Hunting and Trapping
Exchange
Nasdaq
State of incorporation
DE
Record date
January 9, 2017
Distribution date
Ratio
0.449:1
Parent sector
Pharmaceutical Preparations
Form
10-12B/A
Filed
December 29, 2016

Financials — parent vs spin-off

SEC XBRL · latest year
IntrexonFY25
Revenue
$10M
Operating income
−$111M
Net income
−$251M
Total assets
$156M
Equity
$21M
AQUABOUNTY TECHNOLOGIES INCFY25
Revenue
Operating income
−$4M
Net income
−$18M
Total assets
$10M
Equity
−$2M

Latest reported figures from each company's own SEC filings — the parent after the separation and the spin-off as a standalone. Full multi-year history on each company hub.

Spin-off signals

score 2/6 favorable · factors, not advice
  • Focus-increasingYes — Healthcare → Materials

    Spin-offs into a different sector than the parent (pure-plays) have historically outperformed diversifying ones.

  • Leverage (liabilities/assets)118%

    A heavy debt load loaded onto the spin-off is a known risk; a clean balance sheet is favorable.

  • Return on capital employed-251.9%

    EBIT ÷ capital employed — the quality metric the spin-off scorecard research weighs most.

  • Tax-basis reportNone found

    A Form 8937 (basis allocation) accompanies tax-free §355 spin-offs — favorable for taxable holders.

  • Insider buying (post-spin)12 open-market buys

    Officers/directors buying their own newly independent shares (Form 4) has historically preceded outperformance.

  • Time since spin-off9.4 years

    Studies find the spin-off return premium concentrates in roughly the first one to three years.

Factors the spin-off research literature (Greenblatt; Cusatis-Miles-Woolridge; Desai-Jain) associates with outcomes — computed from this company's own SEC filings, shown as factors, not a recommendation. The premium is debated and not guaranteed. How we compute these ↗

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.